Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model

被引:37
作者
Fraternale, A
Casabianca, A
Orlandi, C
Cerasi, A
Chiarantini, L
Brandi, G
Magnani, M
机构
[1] Univ Urbino, Inst Biol Chem Giorgio Fornaini, I-61029 Urbino, PU, Italy
[2] Univ Urbino, Inst Hyg, I-61029 Urbino, Italy
关键词
murine AIDS; macrophages; AZT; DDL; GSH-loaded erythrocytes;
D O I
10.1016/S0166-3542(02)00128-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Monocyte-macrophages play a central role in HIV-1 infection because they are among the first cells to be infected and because later they are important reservoirs for the virus. Thus, newly designed therapies should take into account the protection of this cell compartment. Herein, we report the results obtained in a murine AIDS model, by the addition to AZT+DDI of a system (GSH-loaded erythrocytes) able to protect macrophages against HIV-1 infection. Five groups of LP-BM5-infected mice were treated as follows: one group was treated by AZT, one group was treated by DDI, one group was treated by the combination of both, another by GSH-loaded erythrocytes, and finally, one by the combination of all three, After 10 weeks of infection the parameters of the disease were studied and the proviral DNA content in different organs and in macrophages of bone marrow and of the peritoneal cavity was quantified. The results obtained show that mice treated with AZT+DDI+GSH-loaded erythrocytes showed proviral DNA content in the brain and in macrophages of bone marrow that was significantly lower than in mice treated with AZT+DDI. This study may help developing strategies aimed at blocking HIV-1 replication in its reservoirs in the body. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:263 / 272
页数:10
相关论文
共 41 条
[1]  
Balestra E, 2001, J BIOL REG HOMEOS AG, V15, P272
[2]   Competitive PCR for quantification of BM5d proviral DNA in mice with AIDS [J].
Casabianca, A ;
Vallanti, G ;
Magnani, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (08) :2371-2374
[3]  
CHEUNG SC, 1991, J IMMUNOL, V146, P121
[4]   Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy [J].
Chun, TW ;
Davey, RT ;
Ostrowski, M ;
Justement, JS ;
Engel, D ;
Mullins, JI ;
Fauci, AS .
NATURE MEDICINE, 2000, 6 (07) :757-761
[5]   Latent reservoirs of HIV: Obstacles to the eradication of virus [J].
Chun, TW ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :10958-10961
[6]   Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy [J].
Chun, TW ;
Engel, D ;
Mizell, SB ;
Hallahan, CW ;
Fischette, M ;
Park, S ;
Davey, RT ;
Dybul, M ;
Kovacs, JA ;
Metcalf, JA ;
Mican, JM ;
Berrey, MM ;
Corey, L ;
Lane, HC ;
Fauci, AS .
NATURE MEDICINE, 1999, 5 (06) :651-655
[7]  
CHUN TW, 1997, P NATL ACAD SCI USA, V83, P7089
[8]  
Crowe SM, 2000, J LEUKOCYTE BIOL, V68, P345
[9]   1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity [J].
Daluge, SM ;
Good, SS ;
Faletto, MB ;
Miller, WH ;
StClair, MH ;
Boone, LR ;
Tisdale, M ;
Parry, NR ;
Reardon, JE ;
Dornsife, RE ;
Averett, DR ;
Krenitsky, TA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1082-1093
[10]   Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [J].
Finzi, D ;
Blankson, J ;
Siliciano, JD ;
Margolick, JB ;
Chadwick, K ;
Pierson, T ;
Smith, K ;
Lisziewicz, J ;
Lori, F ;
Flexner, C ;
Quinn, TC ;
Chaisson, RE ;
Rosenberg, E ;
Walker, B ;
Gange, S ;
Gallant, J ;
Siliciano, RF .
NATURE MEDICINE, 1999, 5 (05) :512-517